M
Miriam Hatsue Honda Federico
Researcher at University of São Paulo
Publications - 31
Citations - 1147
Miriam Hatsue Honda Federico is an academic researcher from University of São Paulo. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Cellular differentiation. The author has an hindex of 16, co-authored 31 publications receiving 1072 citations.
Papers
More filters
Journal ArticleDOI
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Stephen Chia,William J. Gradishar,Louis Mauriac,José Bines,Frédéric Amant,Miriam Hatsue Honda Federico,Luis Fein,Gilles Romieu,Aman U. Buzdar,John F.R. Robertson,Adam Brufsky,Kurt Possinger,Pamela Rennie,Francisco Sapunar,Elizabeth S. Lowe,Martine Piccart +15 more
TL;DR: Fulvestrant LD and exemestane are equally active and well-tolerated in a meaningful proportion of postmenopausal women with ABC who have experienced progression or recurrence during treatment with a nonsteroidal AI.
Journal ArticleDOI
Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study
Aline Gouvêa de Lima,R.C. Villar,Gilberto de Castro,Reynaldo Antequera,Erlon Gil,Mauro Cabral Rosalmeida,Miriam Hatsue Honda Federico,Igor Moisés Longo Snitcovsky +7 more
TL;DR: LLL therapy was not effective in reducing severe oral mucositis, although a marginal benefit could not be excluded and it reduced RT interruptions in these head-and-neck cancer patients, which might translate into improved CRT efficacy.
Journal ArticleDOI
High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma.
Gilberto de Castro,Igor Moisés Longo Snitcovsky,Eloisa Maria Mello Santiago Gebrim,Glauber Moreira Leitão,Wladimir Nadalin,Alberto Rossetti Ferraz,Miriam Hatsue Honda Federico +6 more
TL;DR: This concurrent CRT regimen is hardly delivered in stage IV, unresectable, locally advanced HNSCC pts, due to treatment-related toxicities and longer RT duration, as a subset of pts may benefit from this regimen.
Journal ArticleDOI
Efficacy of low-level laser therapy and aluminum hydroxide in patients with chemotherapy and radiotherapy-induced oral mucositis.
Aline Gouvêa de Lima,Reynaldo Antequera,Maria Paula Siqueira De Melo Peres,Igor Moysés Longo Snitcosky,Miriam Hatsue Honda Federico,R.C. Villar +5 more
TL;DR: The prophylactic use of both treatments proposed in this study seems to reduce the incidence of severe OM lesions, however, the LLLT was more effective in delaying the appearance of severeOM.
Journal ArticleDOI
Transforming growth factor β1 (TGFβ1) expression in head and neck squamous cell carcinoma patients as related to prognosis
Angela Flávia Logullo,Suely Nonogaki,Roberto Elias Villela Miguel,Luiz Paulo Kowalski,Inês Nobuko Nishimoto,Fatima Solange Pasini,Miriam Hatsue Honda Federico,Ricardo R. Brentani,Maria Mitzi Brentani +8 more
TL;DR: It is concluded that TGFbeta1 protein immunostaining is not a useful biomarker in assessment of prognosis in HNSCC.